Boston Scientific Makes A Bullish Move After Sales In One Segment Skyrocket 63%

Core Insights - Boston Scientific reported adjusted earnings of 75 cents per share on $5.07 billion in third-quarter sales, exceeding analyst expectations of 71 cents per share and $4.97 billion in sales [1][2] - The company experienced a year-over-year increase in earnings from 63 cents per share and sales of $4.21 billion in the same quarter last year [1] - For the full year, Boston Scientific guided to 20% sales growth on a strict basis and 15.5% organic growth, with projected adjusted earnings between $3.02 and $3.04 per share [2] Stock Performance - In premarket trading, Boston Scientific stock rose over 3% to $102.88, although it remains below its 50-day and 200-day moving averages [3] - The stock is currently consolidating with a buy point at $109.50 according to MarketSurge [3] Analyst Expectations - Analysts projected earnings of $2.98 per share and total sales of $19.88 billion for Boston Scientific, reflecting an almost 19% increase [2]